sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> aptamers market

report

Aptamers Market, By Types (DNA, RNA, XNA), By Application (Diagnostics, Therapeutics Development, Research and Development) Technology (SELEX, Other Technologies), End –user (Academic and Government Research Institutes, Biotechnology and Pharmaceutical Companies, Contract Research Organizations) – Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC319 June 2017 100+ FREE 10% CUSTOMIZATION

Aptamers are multifunctional molecules used for both basic and clinical purposes as macromolecular drugs. They have additional research, industrial and clinical applications. Recently Aptamers have been extensively studied by scientists worldwide. It is found that the functional mechanism and medication method of Aptamers is similar to that of antibodies. Unlike antibodies, aptamers are tested for in-vivo procedures and directly bypasses the in-vitro testing techniques. This not only saves time, but also saves a significant amount of cost involved in several years of R&D during the production of these molecules. These factors have attracted a lot of companies to make investments in this market. This report studies the current and future prospects of the aptamers market.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the aptamers market. The scope of this report covers the aptamers market by its major segments, which include the types, applications, and the major geographic regions.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the market ecosystem and its impact on the revenue growth
  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive
  • Valuable insights into the key technological and market trends impacting this market

KEY PREMIUM INDUSTRY INSIGHTS

  • Aptamers market is increasing globally, as many companies are exploring this molecule and its applications in various medical fields. Advancement in technologies such as reducing the time required in traditional methods and developing newer technologies are some of the market drivers.
  • Factors such as government support, awareness of manufacturers and investment in research are boosting the growth of the aptamers market.
  • However, lack of proper regulatory guidelines related to development of aptamer molecules is hampering the market growth.

The aptamers market is divided into four major geographical segments which are North America, Europe, Asia-Pacific, and the Rest of the World. The North America and European market are most dominant out of which North America is considered to be the highest revenue generating market. These markets contribute the most because of constant advancements in technologies, rise in number of research laboratories and favorable government initiatives. Europe is the evolving market due to factors like emerging aptamer technologies, rise in number of chronic diseases and rise in demand for newer aptamer therapies. Next in line is the Asia-Pacific region. In this region, countries like China and Japan are offering newer growth opportunities to the market by increase in demand for cost effective therapeutics.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s aptamers market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the aptamers market by the following segments:

  • Aptamers Market, by Type
    • DNA-Based Aptamers
    • RNA-Based Aptamers
    • XNA-Based Aptamers
  • Aptamers Market, by Application
    • Diagnostics
    • Therapeutics Development
    • Research and Development
    • Other
  • Aptamers Market, by Technology
    • SELEX
    • Other Technologies
  • Aptamers Market, by End User
    • Academic and Government Research Institutes
    • Biotechnology and Pharmaceutical Companies
    • Contract Research Organizations
    • Other

KEY MARKET PLAYERS

Key players in the aptamers market include:

  • Am Biotechnologies, LLC 
  • Aptagen, LLC 
  • Aptamer Sciences Inc. 
  • Aptamer Solutions Ltd. 
  • Aptus Biotech S.L. 
  • Base Pair Biotechnologies, Inc. 
  • Neoventures Biotechnology Inc. 
  • Somalogic, Inc. 
  • Trilink Biotechnologies, Inc. 
  • Vivonics, Inc. 

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

TRENDING RELATED REPORT

Apheresis Market, by Techniques (Plasmapheresis, Photopheresis, Leukocytapherersis, Erythocytaphereisis, Thrombocytapheresis), Applications (Autoimmune, Renal, Metabolic, Neurological), Technologies (Intermittent-flow Centrifugation, Continuous-flow Centrifugation, Membrane Separation) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Technology Roadmap
  5. APTAMERS MARKET, BY TYPE
    1. Segment Share
    2. By Type
      1. DNA-Based Aptamers
      2. RNA-Based Aptamers
      3. XNA-Based Aptamers
  6. APTAMERS MARKET, BY APPLICATION
    1. Segment Share
    2. By Application
      1. Diagnostics
      2. Therapeutics Development
      3. Research and Development
      4. Other
  7. APTAMERS MARKET, BY TECHNOLOGY
    1. Segment Share
    2. By Technology
      1. SELEX
      2. Other Technologies
  8. APTAMERS MARKET, BY END USER
    1. Segment Share
    2. By End-user
      1. Academic and Government Research Institutes
      2. Biotechnology and Pharmaceutical Companies
      3. Contract Research Organizations
      4. Other
  9. APTAMERS MARKET, BY GEOGRAPHY
    1. Segment Share
    2. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Type
      3. By Application
      4. By Technology
      5. By End-user
    3. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Type
      3. By Application
      4. By Technology
      5. By End-user
    4. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Type
      3. By Application
      4. By Technology
      5. By End-user
    5. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East & Africa
      2. By Type
      3. By Application
      4. By Technology
      5. By End-user
  10. COMPETITIVE LANDSCAPE
    1. Market Positioning of Key Players, 2016
    2. Key Innovators
  11. KEY MARKET PLAYERS
    1. Am Biotechnologies, LLC
      1. Overview
      2. Key Strategies
      3. Key Developments 
    2. Aptagen, LLC
      1. Overview
      2. Key Strategies
      3. Key Developments 
    3. Aptamer Sciences Inc. 
      1. Overview
      2. Key Strategies
      3. Key Developments
    4. Aptamer Solutions Ltd.
      1. Overview
      2. Key Strategies
      3. Key Developments 
    5. Aptus Biotech S.L. 
      1. Overview
      2. Key Strategies
      3. Key Developments
    6. Base Pair Biotechnologies, Inc. 
      1. Overview
      2. Key Strategies
      3. Key Developments
    7. Neoventures Biotechnology Inc. 
      1. Overview
      2. Key Strategies
      3. Key Developments
    8. Somalogic, Inc. 
      1. Overview
      2. Key Strategies
      3. Key Developments
    9. Trilink Biotechnologies, Inc. 
      1. Overview
      2. Key Strategies
      3. Key Developments
    10. Vivonics, Inc. 
      1. Overview
      2. Key Strategies
      3. Key Developments
  12. SCALAR 360 DEGREE MARKET PERSPECTIVE
  13. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us